{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T06:12:26Z","timestamp":1684995146461},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.phrs.2011.03.019","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T18:18:09Z","timestamp":1303496289000},"page":"176-179","source":"Crossref","is-referenced-by-count":3,"title":["2050: Ending the odyssey of the great white plague"],"prefix":"10.1016","volume":"64","author":[{"given":"Mandeep S.","family":"Jassal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace M.","family":"Aldrovandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2011.03.019_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2011.03.019_bib0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1586\/eri.10.60","article-title":"New drugs and regimens for treatment of TB","volume":"8","author":"Leibert","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.phrs.2011.03.019_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tim.2007.12.002","article-title":"Preclinical testing of new drugs for tuberculosis: current challenges","volume":"16","author":"Lenaerts","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.phrs.2011.03.019_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0065-2164(10)71003-0","article-title":"Experimental models used to study human tuberculosis","volume":"71","author":"O\u2019Toole","year":"2010","journal-title":"Adv Appl Microbiol"},{"key":"10.1016\/j.phrs.2011.03.019_bib0025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","article-title":"Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice","volume":"375","author":"Wallis","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2011.03.019_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tube.2006.03.004","article-title":"Volatile biomarkers of pulmonary tuberculosis in the breath","volume":"87","author":"Phillips","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.phrs.2011.03.019_bib0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346053","article-title":"Whole blood bactericidal activity during treatment of pulmonary tuberculosis","volume":"187","author":"Wallis","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.phrs.2011.03.019_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/655471","article-title":"Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers","volume":"202","author":"Wallis","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.phrs.2011.03.019_bib0045","unstructured":"Global Alliance for TB Drug Development. The Critical Path to TB Regimens Initiative. http:\/\/www.tballiance.org\/cptr [accessed 22.02.11]."},{"key":"10.1016\/j.phrs.2011.03.019_bib0050","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/651490","article-title":"Pediatric tuberculosis: global overview and challenges","volume":"50","author":"Swaminathan","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.phrs.2011.03.019_bib0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin: clinical relevance","volume":"42","author":"Niemi","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.phrs.2011.03.019_bib0060","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(09)70282-8","article-title":"Tuberculosis and diabetes mellitus: convergence of two epidemics","volume":"9","author":"Dooley","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.phrs.2011.03.019_bib0065","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(10)60359-9","article-title":"Global tuberculosis drug development pipeline: the need and the reality","volume":"375","author":"Ma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2011.03.019_bib0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/QAD.0b013e328329148e","article-title":"Clinical experience with the combined use of lopinavir\/ritonavir and rifampicin","volume":"23","author":"L\u2019homme","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.phrs.2011.03.019_bib0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1465-9921-7-118","article-title":"Tuberculosis chemotherapy: current drug delivery approaches","volume":"7","author":"du Toit","year":"2006","journal-title":"Respir Res"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661811001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661811001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T01:58:36Z","timestamp":1543802316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661811001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1043661811001009"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2011.03.019","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}